NanoVibronix Announces Completion Of Design Phase For Next-Gen PainShield And UroShield Devices, Advancing To Verification And Testing, Aiming To Lower Costs And Enhance Manufacturing

Development advancing to verification and testing phase; Aims to future-proof design, lower componentry costs and improve manufacturing

NanoVibronix, Inc.(NASDAQ:NAOV) (the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced a third-party contractor engaged by the Company has completed the design phase for the development of the Company's next generation PainShield® and UroShield® devices.

During the design phase, which was completed in December 2024, the third-party contractor developed prototypes of the Company's next generation PainShield® and UroShield® devices that aim to reduce both the cost of assembly and the risk profile and minimize user burden.